A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand

Articles Open Access

Like 0

This item has no PDF Download

A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand
J Holst , I S Aaberge , Philipp Oster , D Lennon , D Martin , J O'Hallahan , K Nord , H Nøkleby , L M Næss , L M Næss , P Kristiansen , A G Skryten , K Bryn , A Aase , R Rappuoli , E Rosenqvist
View Citation Hide Citation

Citation style for this article: Holst J , Aaberge I , Oster Philipp , Lennon D , D Martin , J O'Hallahan , K Nord , H Nøkleby , L M Næss , L M Næss , P Kristiansen , A G Skryten , K Bryn , A Aase , R Rappuoli , E Rosenqvist . A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand. Euro Surveill. 2003;7(30):pii=2262. https://doi.org/10.2807/esw.07.30.02262-en

New Zealand has experienced an epidemic of serogroup B meningococcal infection since 1991

Article metrics loading...

/content/10.2807/esw.07.30.02262-en

2003-07-24

2020-09-25

http://instance.metastore.ingenta.com/content/10.2807/esw.07.30.02262-en

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/7/30/art02262-en.htm?itemId=/content/10.2807/esw.07.30.02262-en&mimeType=html&fmt=ahah

Comment has been disabled for this content

Submit comment

Comment moderation successfully completed